These publications may include information from one or more organism/antimicrobial combinations that are research use only and not for use in diagnostic procedures. Certain uses of devices included in these publications may not have been IVD-approved or cleared by regulatory bodies.
Type
Title
Download
Year
Poster
Evaluation and potential clinical impact of a rapid AST method direct from Gram-negative blood cultures, SWACM 2024.
2024
Poster
Rapid AST results for gram-negative bacteremia and the time to effective and optimal antimicrobial therapy, J. Boelens et al., Ghent University Hospital, Presented at ESICM in Barcelona, 2024.
2024
Poster
The LIFETIMES Study – Interim Results from a Health and Economic Evaluation of a Rapid Phenotypic AST System, ASM Microbe 2024.
2024
Poster
Rapid AST expedites antimicrobial therapy optimisation in BSI patients – clinical cases from the LIFETIMES HEOR study, ESCMID Global 2024.
2024
White Paper
The Health and Economic Impact of Rapid AST in the Management of Bloodstream Infections
Brochure
ASTar - Designed to save lifetimes (US version)
Poster
A new assay for rapid antimicrobial susceptibility testing of bloodstream infection-causing gram-negative bacteria, ASM 2023.
2023
Poster
Performance Evaluation for Piperacillin/Tazobactam in ESBL-Producing E. coli Strains (OXA-1 and TEM-1) in an Automated Rapid AST System Using the New FDA Breakpoints, ASM 2023.
2023
Poster
Fully Automated Phenotypic Resistance Reporting in 3 Hours, Directly from a Positive Blood Culture, ECCMID 2021.
2021
Poster
Accurate inoculum preparation for AST from various samples, ASM 2019.
2019
Poster
Rapid phenotypic AST direct from different clinical specimens as well as isolates on the same automated system, ECCMID 2019.
2019
Poster
Automated inoculum preparation for AST from crude samples, ECCMID 2019.
2019
Poster
Antimicrobial Susceptibility Test System Delivering Phenotypic MICs in Hours from Positive Blood Cultures for Fastidious- and Non-Fastidious Pathogens, ASM 2018.
2018
Poster
Opportunity for very rapid phenotypic susceptibility testing of clinical specimens using the novel ASTar platform, ASM 2018.
2018
Poster
MALDI-TOF MS Identification and Phenotypic AST Delivering True MICs in Hours, Directly from Clinical Positive Blood Cultures, ASM 2018.
2018
Poster
Mass spectrometry pathogen identification and phenotypic antimicrobial susceptibility testing delivering MICs in hours, directly from clinical positive blood cultures, ECCMID 2018.
2018
White Paper
The Importance of Controlled Inoculum
Poster
Performance of a rapid phenotypic AST System for susceptibility testing of Gram-negative bacteraemia directly from positive blood culture bottles, ECCMID 2022.
2022
Poster
Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing, ECCMID 2022.
2022
Poster
Rapid phenotypic AST System performance for Gram-negative bacteraemia susceptibility testing directly from positive blood culture bottles, ASM 2022.
2022
Poster
Using wasted time: How a portable culture device can reduce the impact of transportation times in antimicrobial susceptibility testing, ASM 2022.
2022
Presentations & webinars
RECORDED WEBINAR Clinical Evaluation of an FDA-Cleared High-Throughput Rapid Antibiotic Susceptibility Testing System
Originally broadcasted on September 18, 2024.
Speakers:
Elizabeth Garrett, PhD, D(ABMM)
Associate Director of Microbiology, Penn State Hershey Medical Center
Rebecca Yee, PhD, D(ABMM), M(ASCP)
Chief of Microbiology, Assistant Professor of Pathology, George Washington University
Clinical Impact of rapid antimicrobial susceptibility testing on positive blood cultures from 200 patients with bacteremia: A prospective trial Pr. Alexia Verroken, MD, PD
Recorded presentation from a workshop held at the AMCLI Congress, March 2024 LIFETIMES – Risultati preliminari di uno studio multcentrico di Health Economics (English subtitles) Prof. Maurizio Sanguinetti
Universitá Cattolica del Sacro Cuore, Rome, Italy.
Publications and posters on this page may include performance information for device which is not US-FDA cleared or CE-IVD marked. See Instruction for Use for performance and limitations specific for each device and region.
